| spelling |
oapen-20.500.12657-760982024-03-28T09:43:49Z Governing, Protecting, and Regulating the Future of Genome Editing Slokenberga, Santa Minssen, Timo Nordberg, Ana Advanced Therapy Medicinal Products Biomedicine Convention Article 13 Clinical Trials Regulation Article 90 CRISPR Gene Therapy Genetics and Justice Germline genome editing Health Innovation Morality Exceptions Ordre Public Responsible Regulation Somatic genome editing Vulnerability and epigenome editing This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law. In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society. 2023-09-01T13:12:19Z 2023-09-01T13:12:19Z 2023 book ONIX_20230901_9789004526136_20 9789004526136 9789004526082 https://library.oapen.org/handle/20.500.12657/76098 eng application/pdf Attribution 4.0 International 9789004526136.pdf https://brill.com/edcollbook-oa/title/63467 Brill Nijhoff 10.1163/9789004526136 10.1163/9789004526136 af16fd4b-42a1-46ed-82e8-c5e880252026 d0e1cd83-8ecb-44a2-bba8-187a50881e77 9789004526136 9789004526082 Nijhoff [...] Lund University Library Book Fund Lund University open access
|
| description |
This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law. In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society.
|
